Literature DB >> 20398928

Delivery of paclitaxel from cobalt-chromium alloy surfaces without polymeric carriers.

Gopinath Mani1, Celia E Macias, Marc D Feldman, Denes Marton, Sunho Oh, C Mauli Agrawal.   

Abstract

Polymer-based carriers are commonly used to deliver drugs from stents. However, adverse responses to polymer coatings have raised serious concerns. This research is focused on delivering drugs from stents without using polymers or any carriers. Paclitaxel (PAT), an anti-restenotic drug, has strong adhesion towards a variety of material surfaces. In this study, we have utilized such natural adhesion property of PAT to attach these molecules directly to cobalt-chromium (Co-Cr) alloy, an ultra-thin stent strut material. Four different groups of drug coated specimens were prepared by directly adding PAT to Co-Cr alloy surfaces: Group-A (PAT coated, unheated, and ethanol cleaned); Group-B (PAT coated, heat treated, and ethanol cleaned); Group-C (PAT coated, unheated, and not ethanol cleaned); and Group-D (PAT coated, heat treated and not ethanol cleaned). In vitro drug release of these specimens was investigated using high performance liquid chromatography. Groups A and B showed sustained PAT release for up to 56 days. A simple ethanol cleaning procedure after PAT deposition can remove the loosely bound drug crystals from the alloy surfaces and thereby allowing the remaining strongly bound drug molecules to be released at a sustained rate. The heat treatment after PAT coating further improved the stability of PAT on Co-Cr alloy and allowed the drug to be delivered at a much slower rate, especially during the initial 7 days. The specimens which were not cleaned in ethanol, Groups C and D, showed burst release. PAT coated Co-Cr alloy specimens were thoroughly characterized using scanning electron microscopy, atomic force microscopy, and X-ray photoelectron spectroscopy. These techniques were collectively useful in studying the morphology, distribution, and attachment of PAT molecules on Co-Cr alloy surfaces. Thus, this study suggests the potential for delivering paclitaxel from Co-Cr alloy surfaces without using any carriers. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398928      PMCID: PMC4076912          DOI: 10.1016/j.biomaterials.2010.03.043

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  55 in total

1.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

Authors:  Andrew T L Ong; Eugène P McFadden; Evelyn Regar; Peter P T de Jaegere; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

2.  Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model.

Authors:  Bodo Cremers; Melanie Biedermann; Dirk Mahnkopf; Michael Böhm; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2009-03-12       Impact factor: 5.460

3.  Chemical modification of titanium surfaces for covalent attachment of biological molecules.

Authors:  A Nanci; J D Wuest; L Peru; P Brunet; V Sharma; S Zalzal; M D McKee
Journal:  J Biomed Mater Res       Date:  1998-05

4.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

5.  Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.

Authors:  A W Heldman; L Cheng; G M Jenkins; P F Heller; D W Kim; M Ware; C Nater; R H Hruban; B Rezai; B S Abella; K E Bunge; J L Kinsella; S J Sollott; E G Lakatta; J A Brinker; W L Hunter; J P Froehlich
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

6.  Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel.

Authors:  Sungwon Kim; Ji Young Kim; Kang Moo Huh; Ghanashyam Acharya; Kinam Park
Journal:  J Control Release       Date:  2008-07-10       Impact factor: 9.776

7.  Interaction of endothelial cells with self-assembled monolayers for potential use in drug-eluting coronary stents.

Authors:  Gopinath Mani; Bysani Chandrasekar; Marc D Feldman; Devang Patel; C Mauli Agrawal
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-08       Impact factor: 3.368

8.  Stability of self-assembled monolayers on titanium and gold.

Authors:  Gopinath Mani; Dave M Johnson; Denes Marton; Victoria L Dougherty; Marc D Feldman; Devang Patel; Arturo A Ayon; C Mauli Agrawal
Journal:  Langmuir       Date:  2008-05-30       Impact factor: 3.882

Review 9.  Vascular responses to drug eluting stents: importance of delayed healing.

Authors:  Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-17       Impact factor: 8.311

10.  Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.

Authors:  Byung Ha Lee; Hye Yeong Nam; Taegun Kwon; Sung Joo Kim; Ghee Young Kwon; Hyun Jung Jeon; Hyun Jung Lim; Woo Kyoung Lee; Jong-sang Park; Jai Young Ko; Dae Joong Kim
Journal:  Nephrol Dial Transplant       Date:  2006-03-22       Impact factor: 5.992

View more
  1 in total

Review 1.  Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention.

Authors:  Rebecca A Scott; Alyssa Panitch
Journal:  Biomacromolecules       Date:  2014-07-08       Impact factor: 6.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.